Skip to content

Maravai LifeSciences

Contact

About
Brands
Impact
- Our Impact
- Maravai Foundation
Insights
Investors
Careers

Home | Insights | Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

February, 2024
Cygnus Technologies
Press Release

Maravai LifeSciences and its brands are the proven catalysts for helping deliver novel vaccines, therapeutics and diagnostics with biotech, biopharma and life sciences companies across the globe.

Extraordinary science.
Everyday miracles.

About
Brands
Helpful links

Share price

Connect with us

LinkedIn

Terms
Privacy notice
Site map

© 2024 Maravai LifeSciences. All rights reserved